Immuno-Augmentive Therapy

The clinic only accepts for treatment only patients who have been diagnosed with cancer. Patients are accepted only after the doctors have reviewed the medical records and determined the patient is a good candidate for IAT therapy.

IAT TREATMENT OBJECTIVES

The objective of IAT is to restore the cancer patient's immune competency to a level by which it can control cancer. The body's own complex tumor fighting system may well be the first, the best, and the last line of defense against cancers.

Other than surgical intervention for local tumors, there is generally no cure for most cancers. Restoring the immune system to enable it to destroy cancer cells, therefore, becomes the prime objective in IAT.

IAT TREATMENT OUTCOMES

IAT is not represented as a cure for cancer, but rather a means of restoring the system's natural balance. The restoration of the natural immune system allows the patient's own body to treat itself. The resulting changes can significantly extend the lives of people with cancer, as borne out by clinic records maintained since 1977.

Many times success for patients with advanced metastatic disease is measured by life extension and enhanced quality of life that is many times experienced while undergoing non-toxic IAT provides.

PATIENT PROTOCOL AT THE CENTRE

Typically, patients presenting at the Centre demonstrate an imbalance of immune components believed essential to the control of cancer. The protocol established for IAT is designed to modulate critical immune factors. By objectively measuring therapeutic progress, the immunologic attack on cancer tumors can be directed.

IAT is therefore a two-step procedure:

(1) Evaluation-measuring deficiencies of the immune systems, and

(2) Therapy-replenishing deficient factors by self-injection of sera.

IMMUNOLOGICAL EVALUATION

The immune system of each cancer patient receiving IAT is evaluated once or twice daily, five days a week. Blood tests measure relevant immune components. These data reveal the relative activity of the tumor kill process and immune response

IAT is individualized to the patient. Based on serial individual blood tests, a computer program calculates the amount of therapeutic sera required for each patient to optimize immunologic response to tumors.